We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$869B
AUM Growth
+$32.9B
Cap. Flow
-$6.92B
Cap. Flow %
-0.8%
Top 10 Hldgs %
33.83%
Holding
3,059
New
82
Increased
1,782
Reduced
864
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$2.31B
2
AAPL icon
Apple
AAPL
+$1.58B
3
SHW icon
Sherwin-Williams
SHW
+$1.37B
4
HUBS icon
HubSpot
HUBS
+$1.32B
5
KVUE icon
Kenvue
KVUE
+$1.25B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.37B
2
LRCX icon
Lam Research
LRCX
+$1.54B
3
AMAT icon
Applied Materials
AMAT
+$1.33B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.19B
5
HAL icon
Halliburton
HAL
+$1.16B

Sector Composition

Rank Sector Weight
1 Technology 32.32%
2 Healthcare 15.15%
3 Financials 10.54%
4 Consumer Discretionary 10.48%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTL icon
2176
Castle Biosciences
CSTL
$933M
$595K ﹤0.01%
20,860
+212
+1% +$5.4K
ETD icon
2177
Ethan Allen Interiors
ETD
$583M
$592K ﹤0.01%
18,553
+251
+1% +$7.58K
FORR icon
2178
Forrester Research
FORR
$224M
$589K ﹤0.01%
32,656
+49
+0.2% +$894
FLNC icon
2179
Fluence Energy
FLNC
$2.44B
$588K ﹤0.01%
25,887
+621
+2% +$11.2K
PAGS icon
2180
PagSeguro Digital
PAGS
$2.43B
$588K ﹤0.01%
68,253
+8,159
+14% +$94.3K
PRM icon
2181
Perimeter Solutions
PRM
$5.53B
$588K ﹤0.01%
43,714
+1,246
+3% +$12.9K
SXC icon
2182
SunCoke Energy
SXC
$788M
$587K ﹤0.01%
67,512
+3,500
+5% +$32.4K
EZPW icon
2183
Ezcorp Inc
EZPW
$1.76B
$583K ﹤0.01%
51,919
KFRC icon
2184
Kforce
KFRC
$1.08B
$575K ﹤0.01%
9,349
+183
+2% +$11.7K
NABL icon
2185
N-able
NABL
$695M
$574K ﹤0.01%
43,943
+866
+2% +$11.6K
CTBI icon
2186
Community Trust Bancorp
CTBI
$1.44B
$573K ﹤0.01%
11,524
-4,579
-28% -$219K
RCUS icon
2187
Arcus Biosciences
RCUS
$3.67B
$569K ﹤0.01%
37,213
+715
+2% +$11.3K
GDOT icon
2188
Green Dot
GDOT
$770M
$568K ﹤0.01%
48,474
+293
+0.6% +$3.06K
CWH icon
2189
Camping World
CWH
$675M
$567K ﹤0.01%
23,380
+541
+2% +$11.6K
KNTK icon
2190
Kinetik
KNTK
$4.16B
$566K ﹤0.01%
12,505
+342
+3% +$14.8K
CCO icon
2191
Clear Channel Outdoor Holdings
CCO
$1.18B
$564K ﹤0.01%
351,790
+27,863
+9% +$43.6K
EYE icon
2192
National Vision
EYE
$1.51B
$563K ﹤0.01%
51,519
+764
+2% +$8.91K
NTB icon
2193
Bank of N.T. Butterfield & Son
NTB
$2.51B
$562K ﹤0.01%
15,235
+486
+3% +$18K
NVRO
2194
DELISTED
NEVRO CORP.
NVRO
$562K ﹤0.01%
100,371
+44,716
+80% +$313K
ARQT icon
2195
Arcutis Biotherapeutics
ARQT
$3.25B
$560K ﹤0.01%
60,148
+1,246
+2% +$12.3K
CENX icon
2196
Century Aluminum
CENX
$4.59B
$560K ﹤0.01%
34,450
+687
+2% +$10.4K
CVI icon
2197
CVR Energy
CVI
$3.58B
$558K ﹤0.01%
24,208
+334
+1% +$8.26K
BGS icon
2198
B&G Foods
BGS
$299M
$557K ﹤0.01%
62,715
+5,464
+10% +$46.3K
SCSC icon
2199
Scansource
SCSC
$1.06B
$555K ﹤0.01%
11,539
-4,915
-30% -$233K
SVC
2200
Service Properties Trust
SVC
$1.06B
$553K ﹤0.01%
24,221
+1,991
+9% +$49.5K

Similar funds

T. Rowe Price Associates's Q3 2024 Portfolio in Review

As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
  • T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
  • T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
  • T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.

Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.